“…1 , 2 There was particular concern about the impact of the COVID‐19 pandemic on cancer screening, diagnosis, and treatment. 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 In the early part of the COVID‐19 pandemic (i.e., prior to widespread vaccination), breast cancer imaging, mastectomies, Pap tests, low‐dose computed tomography screening for lung cancer, and colorectal cancer colonoscopy screenings decreased, and there was a reduction in radiological and pathological diagnostic testing. 5 , 6 , 7 , 8 , 9 Cancer patients reported experiencing delays across all treatment types, particularly surgery and radiation therapy.…”